George Nikopoulos - Biotricity Director Development

Director

George Nikopoulos is Director Development of Biotricity
Phone(800) 590-4155
Webhttps://www.biotricity.com

Biotricity Management Efficiency

The company has return on total asset (ROA) of (0.8862) % which means that it has lost $0.8862 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (41.0079) %, meaning that it created substantial loss on money invested by shareholders. Biotricity's management efficiency ratios could be used to measure how well Biotricity manages its routine affairs as well as how well it operates its assets and liabilities.
Biotricity currently holds 23.88 M in liabilities with Debt to Equity (D/E) ratio of 6.45, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Biotricity has a current ratio of 1.51, which is within standard range for the sector. Note, when we think about Biotricity's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 3 records

DIRECTOR Age

Allen BarbieriBiomerica
67
Joel SuiterSurModics
N/A
ChihHeng LuAinos Inc
45
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. Biotricity operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 44 people. Biotricity (BTCY) is traded on NASDAQ Exchange in USA. It is located in 203 Redwood Shores Parkway, Redwood City, CA, United States, 94065 and employs 55 people. Biotricity is listed under Medical Equipment category by Fama And French industry classification.

Management Performance

Biotricity Leadership Team

Elected by the shareholders, the Biotricity's board of directors comprises two types of representatives: Biotricity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biotricity. The board's role is to monitor Biotricity's management team and ensure that shareholders' interests are well served. Biotricity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biotricity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Fareeha Siddiqui, Senior Solutions
Amjad Talpur, Senior Operations
George Nikopoulos, Director Development
Waqaas AlSiddiq, Founder, Chairman, CEO and Executive Officer
Amir Ali, Chief Officer
John Ayanoglou, Chief Officer
Andy Wong, Vice Operations
Matt Zabel, Vice Strategy

Biotricity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biotricity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Biotricity Stock

If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity